Frameshift mutation in the alpha2-globin gene causing alpha+ -thalassemia: codon 49 (-GC)

Area of Science:

• Genetics
• Hematology
• Molecular Biology

Background:

• Alpha-thalassemia (alpha-thal) is a common inherited blood disorder affecting hemoglobin production.
• Point mutations are a significant cause of genetic disorders, including alpha-thalassemia.
• Accurate genetic identification is crucial for understanding disease mechanisms and inheritance patterns.

Purpose of the Study:

• To report the identification and characterization of a new alpha-thalassemia point mutation.
• To elucidate the specific genetic alteration responsible for alpha-thalassemia in the studied patient.
• To contribute to the growing knowledge base of alpha-globin gene mutations.

Main Methods:

• Sequence analysis of the alpha-globin genes (HBA1 and HBA2).
• Identification of genetic variants, including point mutations and insertions/deletions.
• Correlation of genotype with the clinical phenotype of alpha-thalassemia.

Main Results:

• A novel frameshift mutation, designated -GC, was identified at codon 49 in exon 2 of the alpha2-globin gene (HBA2).
• This mutation was detected in a patient diagnosed with alpha-thalassemia.
• The identified mutation is predicted to alter the alpha-globin protein sequence and stability.

Conclusions:

• The novel -GC frameshift mutation in the HBA2 gene is a newly identified cause of alpha-thalassemia.
• This finding expands the spectrum of known alpha-thalassemia mutations.
• Further studies are warranted to understand the full clinical and molecular consequences of this mutation.